Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
17.80
+0.12 (0.68%)
Nov 13, 2026, 4:00 PM EST - Market closed

Ardent Health Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Ardent Health stock has a consensus rating of "Buy" and an average price target of $16.63. The average 1-year stock price forecast is 6.57% lower than the current stock price, while the lowest is $12 (-32.58%) and the highest is $21 (+17.98%).

Price Target: $16.63 (-6.57%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$12$16.63$16.5$21
Change-32.58%-6.57%-7.30%+17.98%

Analyst Ratings

The average analyst rating for Ardent Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy666666
Buy111111
Hold444555
Sell111111
Strong Sell000000
Total121212131313

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Sell
Maintains
$12 → $14
SellMaintains$12 → $14-21.35%Nov 13, 2026
Mizuho Securities
Mizuho Securities
Buy
Maintains
$13 → $21
BuyMaintains$13 → $21+17.98%Nov 11, 2026
UBS
UBS
Buy
Reiterates
$14 → $20
BuyReiterates$14 → $20+12.36%Nov 9, 2026
BMO Capital
BMO Capital
Hold
Reiterates
$11 → $16
HoldReiterates$11 → $16-10.11%Nov 6, 2026
RBC Capital
RBC Capital
Buy
Reiterates
$13 → $18
BuyReiterates$13 → $18+1.12%Nov 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
6.48B
from 6.32B
Increased by 2.42%
Revenue Next Year
6.66B
from 6.48B
Increased by 2.80%
EPS This Year
1.29
from 1.54
Decreased by -16.20%
EPS Next Year
1.41
from 1.29
Increased by 8.71%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
4.87B5.13B5.41B5.97B6.32B6.48B
Revenue Growth
17.02%5.32%5.45%10.29%6.01%2.42%
Operating Income
303.17M200.25M215.84M405.76M325.58M368.39M
Net Income
154.26M188.91M53.90M210.34M135.81M146.34M
EPS
----1.541.29
EPS Growth
-----0.59%-16.20%
Forward PE
---8.796.8313.76
Free Cash Flow
----258.61M122.50M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High6.5B
Avg6.5B
Low6.4B

Revenue Growth

Revenue Growth202620272028
High
2.9%
Avg
2.4%
Low
1.2%

EPS Forecast

EPS202620272028
High1.64
Avg1.29
Low1.07

EPS Growth

EPS Growth202620272028
High
6.2%
Avg
-16.2%
Low
-30.7%